These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34403701)

  • 1. Oral Anticoagulant Use in Morbid Obesity and Post Bariatric Surgery: A Review.
    Nasser MF; Jabri A; Gandhi S; Rader F
    Am J Med; 2021 Dec; 134(12):1465-1475. PubMed ID: 34403701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review.
    Nasser MF; Gandhi S; Siegel RJ; Rader F
    Heart Rhythm; 2021 Feb; 18(2):297-302. PubMed ID: 33022393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis.
    Elshafei MN; Mohamed MFH; El-Bardissy A; Ahmed MB; Abdallah I; Elewa H; Danjuma M
    J Thromb Thrombolysis; 2021 Feb; 51(2):388-396. PubMed ID: 32556939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Oral Anticoagulants for Atrial Fibrillation in Patients After Bariatric Surgery.
    Hendricks AK; Zieminski JJ; Yao X; Dunlay SM; Sangaralingham LR; O'Meara JG; Herrin TR; Nei SD
    Am J Cardiol; 2020 Dec; 136():76-80. PubMed ID: 32941819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients.
    Mohamed MFH; Elewa H; Mubasher M; Danjuma M
    J Thromb Thrombolysis; 2021 Apr; 51(3):701-702. PubMed ID: 32737742
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation.
    Kido K; Shimizu M; Shiga T; Hashiguchi M
    Am J Cardiol; 2020 Jul; 126():23-28. PubMed ID: 32345473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.
    Spyropoulos AC; Ashton V; Chen YW; Wu B; Peterson ED
    Thromb Res; 2019 Oct; 182():159-166. PubMed ID: 31493618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
    Marcy TR; Truong T; Rai A
    Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.
    Peterson ED; Ashton V; Chen YW; Wu B; Spyropoulos AC
    Am Heart J; 2019 Jun; 212():113-119. PubMed ID: 30981035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.
    Kido K; Ngorsuraches S
    Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism.
    Chan NC; Eikelboom JW
    Blood; 2019 May; 133(21):2269-2278. PubMed ID: 30926593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Mhanna M; Beran A; Al-Abdouh A; Sajdeya O; Abdulsattar W; Srour O; Ayesh H; Alom M; Khuder SA; Hamouda D; Assaly R
    Am J Ther; 2021 Jun; 28(5):e531-e539. PubMed ID: 34491953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
    Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R
    PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
    Kalani C; Awudi E; Alexander T; Udeani G; Surani S
    Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
    [No Abstract]   [Full Text] [Related]  

  • 18. PURLs: Direct oral anticoagulants or warfarin for A fib?
    Lyon C; Reed A; Prasad S
    J Fam Pract; 2017 Aug; 66(8):518-519. PubMed ID: 28783771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories.
    Kaplan RM; Tanaka Y; Passman RS; Fine M; Rasmussen-Torvik LJ; Vupputuri S; Martin K; Khan SS
    J Am Heart Assoc; 2020 Dec; 9(24):e017383. PubMed ID: 33302751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How I treat obese patients with oral anticoagulants.
    Wang TF; Carrier M
    Blood; 2020 Mar; 135(12):904-911. PubMed ID: 31978224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.